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A B S T R A C T
In cases of iatrogenic coronary embolism during cardiac surgery or percutaneous coronary intervention,
small air bubbles or foreign bodies are directly injected, which usually result in serious adverse events if
not treated promptly. We herein describe the case of a patient who developed acute myocardial
infarction resulting in shock due to BioGlue1 (CryoLife, Atlanta, GA, USA)-induced coronary embolism
during the surgical repair of aortic dissection and was treated for retrieval of the material using a
thrombectomy catheter.
<Learning objective: Coronary embolism caused by surgical adhesives is a rare but potentially life-
threatening complication. It is important for surgeons to promptly recognize and treat this serious
condition in consultation with cardiologists.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.Introduction
Iatrogenic coronary embolism during invasive cardiovascular
procedures usually results in serious adverse events if not treated
promptly. BioGlue1 (CryoLife, Atlanta, GA, USA) surgical adhesive
is widely used to support the hemostasis of suture-lines, reinforce
or strengthen fragile tissues, and adhere tissues in cardiovascular
surgery [1]. Systemic embolism caused by BioGlue has been
reported [2–4]. In this case report, we present the case of coronary
embolism due to BioGlue during the surgical repair of aortic
dissection in an 86-year-old woman.
Case report
An 86-year-old woman was referred to the internal medicine
outpatient department of our hospital with a complaint of general
malaise. She had a history of three episodes of cerebral infarction. A
12-lead electrocardiogram showed no ischemic changes. A chest
X-ray revealed enlargement of an upper mediastinal shadow,
suggesting aortic dissection. Echocardiography demonstrated* Corresponding author at: Cardiovascular Division, Osaka Minami Medical
Center, 2-1 Kidohigashimachi, Kawachinagano, Osaka 586-8521, Japan.
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1878-5409/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightpreserved left ventricular contractions and a dilated aortic root
without signiﬁcant aortic regurgitation. Contrast-enhanced thor-
aco-abdominal computed tomography showed type A aortic
dissection with a maximum length of the ascending aorta of
52 mm that began in the distal ascending aorta and ended in the
sinotubular junction. The aortic arch and descending aorta did not
appear to be involved. The patient underwent elective surgery to
repair the aortic dissection within 1 month after admission. The
ascending aorta was replaced with a prosthetic graft under
cardiopulmonary bypass and deep hypothermic circulatory arrest
using femoral artery and right atrium cannulation. The proximal
and distal suture-lines were reinforced via the injection of BioGlue
surgical adhesive in the false lumen, and the protruded BioGlue
was carefully trimmed with covered wet gauze on the aortic valve
cusps so as not to spill the fragments of BioGlue into the true
lumen. Prosthetic graft replacement of the ascending aorta was
performed using 4-0 prolene sutures. During rewarming, the
patient developed shock following the discontinuation of cardio-
pulmonary bypass. Shewas returned to the coronary care unitwith
an inserted intra-aortic balloon (IABP) because she did not respond
to inotropic support. A 12-lead ECG showed ST-segment elevation
in the precordial leads, and echocardiography demonstrated an
anteroseptal wall motion abnormality. Surgeons diagnosed her
with acute myocardial infarction and consulted cardiologists for
coronary angiography. The patient underwent urgent coronary
angiography, which revealed abrupt occlusions in the proximals reserved.
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Fig. 1.
Diagnostic coronary angiography showing abrupt occlusion (arrows) in the proximal LAD and distal left circumﬂex artery with no collateral vessels (A–C).
Coronary aspiration via a thrombectomy catheter was performed (the arrowhead indicates the tip of the thrombectomy catheter) (D). The middle portion of the
LAD was inﬂated with a 2.0 mm  12 mm balloon (MINI TREK1, Abbott Vascular, Abbott Park, IL, USA) (E). Final coronary angiography showed successful
reperfusion of the LAD (F).
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the distal portion of the left circumﬂex artery caused by possible
thrombi, with no signiﬁcant collateral vessels (Fig. 1A–C, Video 1).
A 6-Fr Judkins-type catheter was inserted via the femoral
artery approach into the left coronary artery. A 0.014-in. ﬂoppy
guidewire (Runthrough NS Floppy1, Terumo Corp., Tokyo, Japan)
was advanced into the LAD, easily crossing the distal LAD. We
immediately performed thrombus aspiration with a thrombect-
omy catheter (Fig. 1D, EliminateTM, Terumo Clinical Supply, Gifu,
Japan) and retrieved a tiny amount of material (Fig. 2A); however,
the thrombus was not completely removed. Following aspiration,
blood pressure was observed to increase and the patient
recovered from the cardiogenic shock. Coronary angiography
after aspiration revealed the presence of moderate stenosis in the
middle portion of the LAD. Another 0.014-inch guidewire (Neo’s
Rinato, Asahi Intecc Co, Aichi, Japan) was inserted into the
diagonal branch of the LAD to avoid the occluded branch, then an
additional balloon angioplasty with a 2.0 mm  12 mm balloon
(MINI TREK1, Abbott Vascular, Abbott Park, IL, USA) for the[(Fig._2)TD$FIG]
Fig. 2.
The retrieved embolic materials (A) measuring approximately the size of the
revealed no atherosclerotic components and were consistent with histologic s
100).mid-LAD was performed at 8 atm (Fig. 1E). Final coronary
angiography demonstrated successful reperfusion of the LAD
(Fig. 1F, Video 2, thrombolysis inmyocardial infarction ﬂow grade
3). Histologic examinations revealed that no atherosclerotic
components, such as cholesterol or foam cells, were present in
the embolic materials (Fig. 2B) and they were consistent with
histologic specimens of BioGlue (Fig. 2C). As a result, the removed
material was conﬁrmed to be possibly fragments of the BioGlue
that had been used to repair the aortic dissection. Subsequently,
the patient’s creatine kinase (CK) level rose to 5787 U/L, CK-MB
level rose to 421 U/L and Q waves developed in the precordial
leads. Although broad anteroseptal wall motion abnormalities
with a reduced left ventricular ejection fraction (34%) remained,
IABP was withdrawn on the ﬁfth postoperative day, and the
patient’s hemodynamics gradually stabilized. Subsequently,
other surgical procedures, including the treatment of a strangu-
lated femoral hernia and left hip fracture, were performed during
hospitalization, and the patient was discharged on foot 7 months
after the open-heart surgery.tip of an 18-gauge needle. The histologic specimens of the embolic materials (B)
pecimens of BioGlue1 (C) (hematoxylin and eosin staining, original magniﬁcation
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The coronary embolism leading to myocardial infarction has
been recognized to be an uncommon entity exhibiting normal
coronary ﬁndings since Virchow ﬁrst reported the condition in
1856. The prevalence of coronary embolism was 5.2% among
patients identiﬁed to have myocardial infarction on postmortem
coronary angiography [5]. Coronary embolism occurs infrequently
as the coronary arteries have unique anatomical features,
including (a) a smaller caliber than that of the aorta, (b) right
angle emergence inside the sinuses of Valsalva, and (c) protection
of the coronary ostium by aortic valve cusps against the aortic jet
during systole, and physiological features, such as (d) the bulk and
swiftness of the aortic blood current around the coronary ostium
and (e) the ﬁlling blood of the coronary arteries during diastole [6].
On the other hand, in cases of iatrogenic coronary embolism during
invasive cardiovascular procedures, small air bubbles or foreign
bodies are directly injected.
BioGlue, one of the surgical adhesives, is a biological protein
matrix consisting of 45% bovine serum albumin and 10%
glutaraldehyde mixed within the delivery tip, which is believed
by surgeons to facilitate the support of suture-lines for hemostasis,
reinforce fragile tissues, and adhere such tissues [1]. However,
some reports have described complications of systemic embolism
caused by BioGlue [2–4]. There are two previous cases of BioGlue-
induced coronary embolism that occurred within a few days after
the surgical repair of aortic dissection: one was an autopsy case in
which embolism due to surgical adhesive were identiﬁed in the
right and left coronary arteries [3], and the other involved a patient
with acute coronary syndrome treated with stent deployment in
the middle LAD [4]. To the best of our knowledge, this is the ﬁrst
report of the successful retrieval of BioGlue leading to coronary
embolism using a thrombectomy catheter in which the material
was conﬁrmed to be BioGlue based on histologic examinations
conducted during the patient’s life. The use of aspirating coronary
embolic materials with a thrombectomy catheter has been
reported, whereas this procedure can potentially be complicated
by systemic embolism [7]. Therefore, cardiologists must take care
not to dislodge the retrievedmaterials when recovering them from
the coronary arteries.
The mechanisms underlying this complication in the present
case suggest that particles of BioGlue, which may have unfortu-
nately fallen into the left coronary cusp of the aortic valve, moved
into the left coronary artery just after the patient was separated
from cardiopulmonary bypass. The problem highlighted in this
case is how the BioGlue is spilled into the true lumen. With the
exception of accidental dislodgement, Carrel et al. [2] speculated
that BioGlue may leak into the true lumen via suture-line needle
holes. In addition, LeMaire et al. [8] demonstrated an in vitro
incidence of BioGlue leakage of 10%, with no correlations betweenthe suture size and the frequency of such leaks. Establishing the
exact mechanism of leakage in the present case based on a
conference with the surgeons was not possible; however, it cannot
be denied that the fragments of BioGlue used in the surgery spilled
into the true lumen even though the BioGlue was used carefully.
We have continued to use BioGlue even after the occurrence of
this adverse event, with no further complications. There are no
reliable preventive measures other than to use BioGlue carefully,
being precise so as not to spill it into the true lumen. In addition,
this complication may occur with other surgical adhesives and is
not speciﬁc to BioGlue. Based on published data by the Japanese
Association of Thoracic Surgery, the number of surgical replace-
ments of ascending aorta for aortic dissection performedwas 2601
cases in Japan during 2011 [9]. Surgical adhesives would probably
be used inmost cases. On the other hand, according to the results of
research from a post-marketing survey in Japan from June 2011 to
March 2012, serious adverse events associated with the use of
BioGlue occur in approximately 0.15% (6 of around 4000 cases) of
the cases. It is important for surgeons not to perform surgery
without BioGlue, but to promptly recognize and treat this serious
condition in consultation with cardiologists.
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